{"nct_id":"NCT00227422","title":"Assess the Non-inferiority of GSK Biologicals' Mencevax™ ACWY (Manufactured by a New Process) vs Mencevax™ ACWY (the Already Existing Vaccine in the Market) When Given as a Single Dose to Subjects Aged 2-30 Yrs","status":"COMPLETED","status_verified_date":"2016-09","start_date":"2005-06","start_date_type":null,"primary_completion_date":null,"primary_completion_date_type":null,"completion_date":"2005-11","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["GSK"]}